Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR-1210), a novel anti-PD-1 antibody.

Thorac Cancer · 2019 · PMC6558460 · PMID 31017739

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

Identification of prognostic factors In the initial step, we identified six significant or borderline significant factors that were associated with OS in the univariate analysis, including serum LDH, serum CRP, AMC, ECOG PS, number of organs involved, and liver metastasis (Table S1 ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.